查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824166

全球精准医疗市场：2025-2030年未来预测

Global Precision Medicine Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

精准医疗市场规模

精准医疗市场预计将从 2025 年的 1,092.97 亿美元成长到 2030 年的 1,865.06 亿美元，复合年增长率为 11.28%。

精准医疗市场：分析概述

市场概况

精准医疗，又称个人化医疗，是指医师根据对个别病患基因的了解来选择治疗方案的医疗方法。市场发展的主要驱动力是慢性疾病（包括心血管疾病、肥胖及其相关疾病）的日益普及。随着医疗保健系统寻求更有针对性和更有效的治疗性介入，这种个人化治疗方法正日益受到青睐。

全球慢性病负担的增加是市场成长的主要驱动力。心血管疾病是全球主要死亡原因之一，约占全球死亡人数的31%。大多数心血管相关死亡是由中风和心臟病发作引起的，因此对能够提供更有针对性的预防和治疗策略的精准医疗方法的需求巨大。

应用于慢性疾病

认知障碍和阿兹海默症

阿兹海默症及其相关的认知障碍是精准医疗技术的重要应用领域。目前的预测显示，受此影响的人数将显着增加，预计到2050年，美国阿兹海默症人数将达到约1,400万人。这一人口趋势正在推动针对认知障碍的精准医疗解决方案的持续市场需求。

研究和开发正在揭示治疗有效性的重要见解。布法罗大学的科学家发现，75% 的美国人体内都存在一个人类基因，这可能是导致一种治疗阿兹海默症的药物在动物模型中显示出良好效果，但在人体研究中却失败的原因。这项发现凸显了精准医疗方法相对于传统治疗方法的重要性，并预示了基于基因的治疗策略的市场潜力。

糖尿病治疗中的应用

糖尿病是精准医疗市场成长的另一个大驱动力。美国国家糖尿病、消化和肾臟疾病研究所已将精准医疗列为其糖尿病基因组学和遗传学计画的重点，该计画旨在识别能够预防第1型和第2型糖尿病的基因间区域和基因。

医疗保健机构正在实施精准医疗技术来治疗糖尿病，并且取得了令人欣喜的成果。麻省总医院的一项研究表明，以个人基因图谱和数据为重点的干预措施成功降低了第二型糖尿病的风险，证明了精准医疗方法在糖尿病管理中的有效性。

数位健康整合

卫生系统正在透过数位健康计画拓展其精准医疗能力。路易斯安那州卫生系统（Ochsner Health）为患者提供全面的数位健康解决方案，并大力投资开发直接面向消费者的远端医疗服务和交付系统。未来10年，该组织计画将远端医疗服务扩展到重症监护室（ICU）、精神科和中风护理领域，展现精准医疗与数位医疗交付的融合。

癌症治疗应用

癌症治疗是精准医疗市场扩张的主要驱动力。癌症是全球第二大死因，每年约有960万人死亡。约70%的癌症死亡发生在中低收入国家，凸显了精准医疗解决方案在全球市场的巨大机会。

由于癌症发展过程中基因会不断变化，精准医疗方法尤其适用于癌症治疗。科学家正在努力开发并实施基因检测，以确定针对每个癌症病例和肿瘤的最佳治疗方法。这种个人化方法解决了癌症病理的异质性，并透过标靶治疗选择来改善治疗效果。

研发机构正在开发综合资料库，以加速精准医疗疗法的开发。多个机构正在合作建立头颈癌资料库，以加速精准医疗治疗方法的开发和生产。这些资料库正在揭示关键的癌症相关蛋白质和基因，加深我们对癌症路径的理解。

技术进步和伙伴关係

精准医疗市场透过策略伙伴关係和技术创新不断发展。基因序列测定是精准医疗发展的基础，产业合作致力于提升完整的基因组分析能力。这些伙伴关係正在推动多个治疗领域创新精准医疗解决方案的发展。

市场展望

精准医疗市场展现出强劲的成长潜力，这得益于慢性病盛行率的不断上升、技术进步以及医疗体系对个人化治疗方法的采用。对基因的理解及其与临床照护的结合，为针对各种疾病状态的更有效、更有针对性的治疗性介入创造了机会。

本报告的主要优点

  • 深刻分析：获得深入的市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业所采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，既有利又划算。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 分析范围
  • 细分市场

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章 全球精准医疗市场（按技术）

  • 介绍
  • 数据分析（包括人工智慧/机器学习）
  • 生物资讯学
  • 基因序列分析
  • 基因组学/功能基因组学
  • 蛋白质体学
  • 代谢体学
  • 数位健康技术
  • 伴随诊断

第六章全球精准医疗市场的应用

  • 介绍
  • 瘤
  • 中枢神经系统疾病
  • 免疫疾病
  • 心血管疾病
  • 罕见疾病
  • 感染疾病
  • 呼吸系统疾病
  • 代谢紊乱
  • 血液疾病

第七章全球精准医疗市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第八章竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪表板

第九章：公司简介

  • Thermo Fisher Scientific Inc.
  • AstraZeneca plc
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Nordic Bioscience A/S
  • Medtronic
  • Novartis AG
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Bristol Myers Squibb

第十章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称

图表列表

表格列表

简介目录
Product Code: KSI061611054

Precision Medicine Market Size:

The precision medicine market is expected to grow from USD 109.297 billion in 2025 to USD 186.506 billion in 2030, at a CAGR of 11.28%.

Precision Medicine Market Report Summary

Market Overview

Precision medicine, also known as personalized medicine, represents a medical approach where doctors select treatments based on genetic understanding of individual patients. The market is primarily driven by the increasing prevalence of chronic diseases including cardiovascular diseases, obesity, and related conditions. This personalized approach to treatment has gained significant traction as healthcare systems seek more targeted and effective therapeutic interventions.

The market growth is substantially influenced by the global burden of chronic diseases. Cardiovascular diseases represent one of the major causes of death worldwide, accounting for approximately 31% of global deaths. Most cardiovascular-related deaths result from strokes and heart attacks, creating substantial demand for precision medicine approaches that can provide more targeted prevention and treatment strategies.

Chronic Disease Applications

Cognitive Disorders and Alzheimer's Disease

Alzheimer's disease and related cognitive disorders represent significant applications for precision medicine technology. Current projections indicate substantial growth in affected populations, with estimates suggesting the number of Americans living with Alzheimer's disease could reach approximately 14 million by 2050. This demographic trend drives sustained market demand for precision medicine solutions targeting cognitive disorders.

Research developments have revealed important insights into treatment effectiveness. Scientists at the University of Buffalo discovered that a human gene present in 75% of the American population contributes to why certain Alzheimer's disease medications fail in human studies despite showing promising results in animal studies. This discovery highlights the importance of precision medicine approaches over conventional treatments and demonstrates the market potential for genetically-informed therapeutic strategies.

Diabetes Treatment Applications

Diabetes represents another major driver for precision medicine market growth. The National Institute of Diabetes and Digestive and Kidney Diseases has made precision medicines a major priority for its Diabetes Genomics and Genetics Program. The program aims to identify intergenic regions and genes that provide protection against type 1 and type 2 diabetes.

Medical institutions are implementing precision medicine techniques for diabetes treatment with promising results. Massachusetts General Hospital research demonstrated that interventions focused on individuals' genetic profiles and data successfully reduced type 2 diabetes risk, validating the precision medicine approach for diabetes management.

Digital Health Integration

Healthcare systems are expanding precision medicine capabilities through digital health programs. The Louisiana Health system (Ochsner Health) provides comprehensive digital health solutions to patients and has made substantial investments in developing direct-to-consumer telemedicine care services and delivery systems. The organization plans to expand telehealth services for ICU, psychiatry, and stroke care applications over the next decade, demonstrating the integration of precision medicine with digital healthcare delivery.

Cancer Treatment Applications

Cancer treatment represents a primary driver for precision medicine market expansion. Cancer ranks as the second major cause of death worldwide, with an estimated 9.6 million deaths annually. Approximately 70% of cancer deaths occur in lower and middle-income countries, highlighting global market opportunities for precision medicine solutions.

Cancer treatment applications are particularly suited for precision medicine approaches because genetic changes constantly occur in cancer development. Scientists are working to identify and conduct genetic tests that determine optimal treatment approaches for individual cancer cases and tumors. This personalized approach addresses the heterogeneity of cancer presentations and improves treatment outcomes through targeted therapeutic selection.

Research institutions are developing comprehensive databases to accelerate precision medicine therapy development. Collaborative efforts involving multiple organizations have compiled databases of head and neck cancers to speed development and production of precision medicine therapies. These databases provide clarification of key cancer-associated proteins and genes, resulting in advancement of cancer pathway understanding.

Technological Advancement and Partnerships

The precision medicine market continues evolving through strategic partnerships and technological innovation. Genetic sequencing represents a fundamental component of precision medicine development, with industry collaborations focused on advancing complete genomic profiling capabilities. These partnerships drive development of novel and innovative precision medicine solutions across multiple therapeutic areas.

Market Outlook

The precision medicine market demonstrates strong growth potential driven by chronic disease prevalence, technological advancement, and healthcare system adoption of personalized treatment approaches. The integration of genetic understanding with clinical care creates opportunities for more effective, targeted therapeutic interventions across diverse medical conditions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Precision Medicine Market Segments:

By Technology

  • Data Analytics (including AI/ML)
  • Bioinformatics
  • Gene Sequencing
  • Genomics/Functional Genomics
  • Proteomics
  • Metabolomics
  • Digital Health Technologies
  • Companion Diagnostics

By Application

  • Oncology
  • Central Nervous System
  • Immunology
  • Cardiovascular
  • Rare Diseases
  • Infectious Diseases
  • Respiratory Diseases
  • Metabolic Disorders
  • Hematology

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PRECISION MEDICINE MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Data Analytics (including AI/ML)
  • 5.3. Bioinformatics
  • 5.4. Gene Sequencing
  • 5.5. Genomics/Functional Genomics
  • 5.6. Proteomics
  • 5.7. Metabolomics
  • 5.8. Digital Health Technologies
  • 5.9. Companion Diagnostics

6. GLOBAL PRECISION MEDICINE MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Oncology
  • 6.3. Central Nervous System
  • 6.4. Immunology
  • 6.5. Cardiovascular
  • 6.6. Rare Diseases
  • 6.7. Infectious Diseases
  • 6.8. Respiratory Diseases
  • 6.9. Metabolic Disorders
  • 6.10. Hematology

7. GLOBAL PRECISION MEDICINE MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Thermo Fisher Scientific Inc.
  • 9.2. AstraZeneca plc
  • 9.3. F. Hoffmann-La Roche Ltd
  • 9.4. Pfizer Inc.
  • 9.5. Nordic Bioscience A/S
  • 9.6. Medtronic
  • 9.7. Novartis AG
  • 9.8. QIAGEN
  • 9.9. Quest Diagnostics Incorporated
  • 9.10. Bristol Myers Squibb

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES